American Scientific Resources, Incorporated (ASFX)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
American Scientific Resources, Incorporated (ASFX) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Die Aktie erzielt 50/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 16. März 2026American Scientific Resources, Incorporated (ASFX) Gesundheitswesen & Pipeline-Uebersicht
American Scientific Resources, Incorporated, currently in liquidation, formerly operated in the medical instruments and supplies sector, focusing on developing and distributing products for both children and adults. Its product line included thermometers, respiratory devices, and other healthcare aids, primarily distributed through retail channels and online platforms. The company was based in Weston, Florida.
Investmentthese
American Scientific Resources, Incorporated presents a complex investment case due to its current liquidation status. The company's past focus on developing and distributing medical devices for children and adults suggests a potential market opportunity, but its financial instability and subsequent liquidation significantly undermine any investment appeal. The company's negative free cash flow of $-0.00B and a market capitalization of $0.00B further highlight its distressed state. While its products once addressed specific needs in the healthcare market, the liquidation process raises substantial concerns about asset recovery and potential returns for investors. The company's beta of -3.31 may indicate low volatility, but this is largely irrelevant given its liquidation status.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap of $0.00B reflects the company's liquidation status and lack of active trading.
- Gross Margin of 21.5% indicates the profitability of products before liquidation, but is not indicative of current financial health.
- Free Cash Flow of $-0.00B highlights the company's financial struggles leading to liquidation.
- Beta of -3.31 suggests a low correlation with the market, but is not a relevant metric given the company's current state.
- Liquidation status indicates significant financial distress and potential loss of investment.
Wettbewerber & Vergleichsunternehmen
Staerken
- N/A: Given the company's liquidation status, it no longer possesses any strengths.
Schwaechen
- Liquidation status
- Financial instability
- Lack of ongoing operations
Katalysatoren
- N/A: The company is in liquidation.
Risiken
- Ongoing: Liquidation process may result in complete loss of investment.
- Ongoing: Lack of financial transparency due to OTC Other status.
- Ongoing: Minimal trading volume and liquidity.
Wachstumschancen
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
- N/A: American Scientific Resources, Incorporated is currently in liquidation, and therefore has no growth opportunities.
Chancen
- N/A: Given the company's liquidation status, it has no opportunities.
Risiken
- N/A: Given the company's liquidation status, it faces no threats.
Wettbewerbsvorteile
- N/A: Given the company's liquidation status, it no longer possesses a sustainable competitive advantage or 'moat'.
Ueber ASFX
American Scientific Resources, Incorporated was a developer, manufacturer, and distributor of medical products and devices aimed at both children and adults. Founded with the mission of providing innovative healthcare solutions, the company offered a diverse portfolio of products designed to address various needs within the healthcare market. Its product lineup included the Thermofocus 5-in-1 non-contact clinical thermometer, VeraTemp and VeraTemp+ non-contact thermometers, and the Scald Safe Water temperature disc, designed to prevent scalding in baby baths. Additionally, the company offered WhistleWatch, a flow monitoring device for children with respiratory issues, and the Kidz-Med portable ultrasonic nebulizer for treating conditions like asthma and bronchitis. Further expanding its product range, American Scientific Resources provided the Kidz-Med Medicine Dispenser, the Kidz-Med Mommy Recorder, Bip DVDs, the Mebby product line (including breast pumps and baby bottles), and Wee Target. The company also offered the Disintegrator, a home needle and lancet destruction device. Distribution was primarily achieved through retail drug and grocery chains, medical suppliers, its own website, and other online platforms. However, on February 27, 2012, an involuntary petition for liquidation under Chapter 7 was filed against the company, and the petition was approved on March 28, 2012. As of 2026, American Scientific Resources, Inc. is in liquidation.
Was das Unternehmen tut
- Developed and manufactured medical products for children and adults.
- Offered non-contact clinical thermometers.
- Provided respiratory monitoring devices.
- Developed devices for safe baby care, such as bath water temperature discs.
- Distributed products through retail drug and grocery chains.
- Sold products through its website and online platforms.
Geschaeftsmodell
- Developed and manufactured medical devices.
- Distributed products through retail and online channels.
- Generated revenue through product sales.
Branchenkontext
American Scientific Resources, Incorporated operated within the medical instruments and supplies industry, a sector characterized by continuous innovation and stringent regulatory oversight. The market is driven by factors such as an aging population, increasing prevalence of chronic diseases, and technological advancements in medical devices. Competitors in this space, such as CEVE, HCANF, HSMD, LOWLF, and MDIT, operate in a dynamic environment where product differentiation and regulatory compliance are critical for success. However, given American Scientific Resources' liquidation status, it no longer actively participates in or influences the competitive landscape.
Wichtige Kunden
- Parents and caregivers of infants and children.
- Adults requiring medical devices for personal health monitoring.
- Retail drug and grocery chains.
- Medical suppliers.
Finanzdaten
Chart & Info
American Scientific Resources, Incorporated (ASFX) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer ASFX verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ASFX.
Kursziele
Wall-Street-Kurszielanalyse fuer ASFX.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von ASFX auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
ASFX OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, encompassing companies that may not meet the minimum financial standards or have chosen not to provide current information to the market. These securities are often speculative and carry a high degree of risk due to the limited information available and the potential for fraud or manipulation. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face minimal listing requirements, resulting in greater uncertainty for investors. This tier includes companies in bankruptcy, liquidation, or those with questionable business operations.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited or no financial disclosure
- High potential for fraud or manipulation
- Low liquidity and wide bid-ask spreads
- Bankruptcy or liquidation status
- Lack of regulatory oversight
- Verify the company's liquidation status with the US Bankruptcy Court for the Southern District of Florida.
- Review any available financial reports, if any exist.
- Assess the potential for asset recovery in liquidation.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC Other securities.
- Check for any regulatory actions or legal proceedings against the company.
- N/A: Given the company's liquidation status, there are no legitimacy signals.
ASFX Healthcare Aktien-FAQ
What are the key factors to evaluate for ASFX?
American Scientific Resources, Incorporated (ASFX) currently holds an AI score of 50/100, indicating moderate score. Key strength: N/A: Given the company's liquidation status, it no longer possesses any strengths.. Primary risk to monitor: Ongoing: Liquidation process may result in complete loss of investment.. This is not financial advice.
How frequently does ASFX data refresh on this page?
ASFX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ASFX's recent stock price performance?
Recent price movement in American Scientific Resources, Incorporated (ASFX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: N/A: Given the company's liquidation status, it no longer possesses any strengths.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ASFX overvalued or undervalued right now?
Determining whether American Scientific Resources, Incorporated (ASFX) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ASFX?
Before investing in American Scientific Resources, Incorporated (ASFX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding ASFX to a portfolio?
Potential reasons to consider American Scientific Resources, Incorporated (ASFX) depend on individual investment goals and risk tolerance. A key strength identified by analysis: N/A: Given the company's liquidation status, it no longer possesses any strengths.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of ASFX?
Yes, most major brokerages offer fractional shares of American Scientific Resources, Incorporated (ASFX) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track ASFX's earnings and financial reports?
American Scientific Resources, Incorporated (ASFX) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ASFX earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Information is based on available historical data and the company's liquidation status.
- The company is in liquidation, which significantly impacts its financial viability and investment potential.